MRVI CapEx to Revenue

Maravai Lifesciences Holdings Inc · CapEx to Revenue

MRVI logo

MRVI CapEx to Revenue

Current (TTM)4.72%
MRVI CapEx/Revenue (2.92% → 4.72%)
High-resolution chart · PNG

MRVI capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Maravai Lifesciences Holdings Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.0791%
11.4428%
22.687%
1.9354%
1.858%
8.9434%
11.9799%
2.916%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.